Health
Inflammation marker linked to increased fatigue in prostate cancer patients treated with ADT – News-Medical.Net
Prostate cancer is one of the most common cancers among men in the U.S. For many patients, hormone therapy is a treatment option.
Prostate cancer is one of the most common cancers among men in the U.S. For many patients, hormone therapy is a treatment option. This type of therapy, also called androgen deprivation therapy (ADT), reduces the level of testosterone and other androgens in the body. Lowering androgen levels can make prostate cancer cells grow more slowly or shrink tumors over time. However, patients receiving ADT often experience higher levels of fatigue, depression and cognitive impairment.
Moffitt Cancer Center…
-
General20 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General18 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News22 hours agoBrisbane bands unite to help bassist’s cancer fight
-
Noosa News23 hours agoBoat crash in Helensvale on the Gold Coast leaves man with life-threatening burns and another one injured